Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
Schisandrol B
Cat. No.:
OB0225LY-0336
Appearance:
Solid
Purity:
≥99%
Identity:
Confirmed by NMR and HPLC.
Size:
Product Overview
Description:
Schisandrol B is a bioactive ingredient with antioxidant and neuroprotective properties.
Synonym:
Gomisin A; TJN-101; Besigomsin; Gamma-Schisandrin; 58546-54-6; Benzo(3,4)cycloocta(1,2-f)(1,3)benzodioxol-6-ol, 5,6,7,8-tetrahydro-6,7-dimethyl-1,2,3,13-tetramethoxy-, stereoisomer
CAS No.:
58546-54-6
Compound CID:
3001662
Formula:
C23H28O7
Formula Weight:
416.46
Specification
Relative Density:
1.21 g/cm3
Stability:
3 years in powder form.
Storage:
Storage at -20°C.
Applications:
Schisandrol B can be used in the study of antioxidant effects or play an important role in the study of neuroprotective mechanisms.
Library Information
Targets:
Reactive oxygen species; P450
Pathways:
Immunology/Inflammation; Metabolism; NF-κB; Autophagy
Plate Number:
AOCL-5
Plate Location:
c10
Empty Location:
a1-h1; a12-h12
Container:
96-well plate
Formulation:
10 mM DMSO
DMSO Max Solubility:
50 mg/mL; 120.06 mM
